TREating Pediatric Obesity

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 27, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Infant ObesityHepatic SteatosisMetabolic SyndromeInsulin ResistanceDyslipidemias
Interventions
BEHAVIORAL

Standard Care

Participants will receive nutritional education sessions and will be instructed to maintain an intake window of at least 13 hours a day, preferably every day of the week and in any case at least 6 days a week.

BEHAVIORAL

Time restricted eating

A personalized progression will be established to progressively reduce the intake window during the first 10 days of intervention. After these first 10 days, the participants will be prescribed to limit food intake to a maximum of 10 hours a day, at least 5 days a week. Participant can freely select the time of day to place the intake window. However, it will be recommended to avoid making the last intake in the 3 hours before going to bed. After 4 weeks of intervention, the dietitian will invite them to reduce the intake window to 9 or 8 hours, if they consider it feasible, maintaining this new intake window during the last 4 weeks of intervention. The intake window can be maintained at 10 hours until the end of the study.

Trial Locations (1)

29011

Hospital Regional Universitario de Málaga. Hospital Materno-Infantil., Málaga

All Listed Sponsors
lead

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

OTHER

NCT05124847 - TREating Pediatric Obesity | Biotech Hunter | Biotech Hunter